Genesco Statistics
Total Valuation
Genesco has a market cap or net worth of $368.31 million. The enterprise value is $916.91 million.
| Market Cap | 368.31M |
| Enterprise Value | 916.91M |
Important Dates
The last earnings date was Friday, May 29, 2026, before market open.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Genesco has 11.11 million shares outstanding. The number of shares has decreased by -1.12% in one year.
| Current Share Class | 11.11M |
| Shares Outstanding | 11.11M |
| Shares Change (YoY) | -1.12% |
| Shares Change (QoQ) | -2.81% |
| Owned by Insiders (%) | 13.57% |
| Owned by Institutions (%) | 91.57% |
| Float | 9.60M |
Valuation Ratios
The trailing PE ratio is 17.88 and the forward PE ratio is 12.43.
| PE Ratio | 17.88 |
| Forward PE | 12.43 |
| PS Ratio | 0.15 |
| Forward PS | 0.15 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.72 |
| P/FCF Ratio | 4.31 |
| P/OCF Ratio | 2.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.42, with an EV/FCF ratio of 10.73.
| EV / Earnings | 46.59 |
| EV / Sales | 0.37 |
| EV / EBITDA | 11.42 |
| EV / EBIT | 33.83 |
| EV / FCF | 10.73 |
Financial Position
The company has a current ratio of 1.83, with a Debt / Equity ratio of 1.04.
| Current Ratio | 1.83 |
| Quick Ratio | 0.23 |
| Debt / Equity | 1.04 |
| Debt / EBITDA | 1.53 |
| Debt / FCF | 6.74 |
| Interest Coverage | 7.28 |
Financial Efficiency
Return on equity (ROE) is 3.66% and return on invested capital (ROIC) is 1.94%.
| Return on Equity (ROE) | 3.66% |
| Return on Assets (ROA) | 1.21% |
| Return on Invested Capital (ROIC) | 1.94% |
| Return on Capital Employed (ROCE) | 2.56% |
| Weighted Average Cost of Capital (WACC) | 5.88% |
| Revenue Per Employee | $153,072 |
| Profits Per Employee | $1,230 |
| Employee Count | 16,000 |
| Asset Turnover | 1.76 |
| Inventory Turnover | 2.83 |
Taxes
In the past 12 months, Genesco has paid $6.69 million in taxes.
| Income Tax | 6.69M |
| Effective Tax Rate | 25.38% |
Stock Price Statistics
The stock price has increased by +55.03% in the last 52 weeks. The beta is 1.83, so Genesco's price volatility has been higher than the market average.
| Beta (5Y) | 1.83 |
| 52-Week Price Change | +55.03% |
| 50-Day Moving Average | 35.79 |
| 200-Day Moving Average | 30.92 |
| Relative Strength Index (RSI) | 41.43 |
| Average Volume (20 Days) | 206,625 |
Short Selling Information
The latest short interest is 848,063, so 7.64% of the outstanding shares have been sold short.
| Short Interest | 848,063 |
| Short Previous Month | 977,848 |
| Short % of Shares Out | 7.64% |
| Short % of Float | 8.83% |
| Short Ratio (days to cover) | 3.99 |
Income Statement
In the last 12 months, Genesco had revenue of $2.45 billion and earned $19.68 million in profits. Earnings per share was $1.85.
| Revenue | 2.45B |
| Gross Profit | 1.13B |
| Operating Income | 27.10M |
| Pretax Income | 26.38M |
| Net Income | 19.68M |
| EBITDA | 80.28M |
| EBIT | 27.10M |
| Earnings Per Share (EPS) | $1.85 |
Balance Sheet
The company has $27.12 million in cash and $575.72 million in debt, with a net cash position of -$548.60 million or -$49.39 per share.
| Cash & Cash Equivalents | 27.12M |
| Total Debt | 575.72M |
| Net Cash | -548.60M |
| Net Cash Per Share | -$49.39 |
| Equity (Book Value) | 552.44M |
| Book Value Per Share | 49.68 |
| Working Capital | 270.92M |
Cash Flow
In the last 12 months, operating cash flow was $144.02 million and capital expenditures -$58.57 million, giving a free cash flow of $85.45 million.
| Operating Cash Flow | 144.02M |
| Capital Expenditures | -58.57M |
| Depreciation & Amortization | 53.18M |
| Net Borrowing | -76.13M |
| Free Cash Flow | 85.45M |
| FCF Per Share | $7.69 |
Margins
Gross margin is 46.33%, with operating and profit margins of 1.11% and 0.80%.
| Gross Margin | 46.33% |
| Operating Margin | 1.11% |
| Pretax Margin | 1.08% |
| Profit Margin | 0.80% |
| EBITDA Margin | 3.28% |
| EBIT Margin | 1.11% |
| FCF Margin | 3.49% |
Dividends & Yields
Genesco does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.12% |
| Shareholder Yield | n/a |
| Earnings Yield | 5.34% |
| FCF Yield | 23.20% |
Analyst Forecast
The average price target for Genesco is $40.33, which is 21.62% higher than the current price. The consensus rating is "Hold".
| Price Target | $40.33 |
| Price Target Difference | 21.62% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 1.88% |
| EPS Growth Forecast (3Y) | 31.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Genesco has an Altman Z-Score of 2.54 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.54 |
| Piotroski F-Score | 6 |